Serina Therapeutics (SER) Net Cash Flow (2018 - 2025)
Serina Therapeutics (SER) posted Net Cash Flow of -$5.6 million for Q4 2025, down 314.14% sequentially from $2.6 million in Q3 2025, and down 1375.51% YoY from $437000.0 in Q4 2024.
Serina Therapeutics (SER) Net Cash Flow (2018 - 2025) Analysis & Trends
Serina Therapeutics has reported Net Cash Flow for 8 years, with the latest figure at -$5.6 million in Q4 2025.
- Quarterly Net Cash Flow fell 1375.51% year-over-year to -$5.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$602000.0 (up 84.75% YoY) and the FY2025 annual result came in at -$602000.0, up 84.75% from the prior year.
- Net Cash Flow eased to -$5.6 million in Q4 2025 per SER's latest filing, from $2.6 million in the prior quarter.
- Over five years, Net Cash Flow peaked at $8.8 million in Q2 2023 and troughed at -$5.6 million in Q4 2025.
- A 5-year average of $132800.0 and a median of $108500.0 in 2022 frame the typical range for Net Cash Flow.
- The sharpest annual moves came in 2023 and 2025: Net Cash Flow surged 3368.5% in 2023, then tumbled 1375.51% in 2025.
- Over 5 years, Net Cash Flow stood at -$287000.0 in 2021, then jumped by 162.37% to $179000.0 in 2022, then tumbled by 78.77% to $38000.0 in 2023, then surged by 1050.0% to $437000.0 in 2024, then sank by 1375.51% to -$5.6 million in 2025.
- According to Business Quant data, Net Cash Flow over the past three periods registered -$5.6 million, $2.6 million, and $1.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.35 Bn | 131.49 Bn | 2.84 Bn | 652.90 Mn |
| 2 | Regeneron Pharmaceuticals | 86.24 Bn | 78.25 Bn | 3.93 Bn | -504.30 Mn |
| 3 | Argenx Se | 65.26 Bn | 60.08 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.83 Bn | 53.69 Bn | 52.00 Mn | -183.00 Mn |
| 5 | BeOne Medicines | 42.10 Bn | 37.00 Bn | 1.53 Bn | 407.41 Mn |
| 6 | Alnylam Pharmaceuticals | 31.68 Bn | 28.37 Bn | 992.69 Mn | -496,000.00 |
| 7 | BioNTech SE | 27.95 Bn | 9.56 Bn | 668.28 Mn | -2.83 Bn |
| 8 | Insmed | 27.50 Bn | 26.34 Bn | 358.27 Mn | -37.14 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.44 Bn | - | 225.59 Mn |
| 10 | Serina Therapeutics | 43.44 Mn | 20.41 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -5.57 Mn |
| Dec 31, 2025 | -5.57 Mn |
| Sep 30, 2025 | 2.60 Mn |
| Sep 30, 2025 | 2.60 Mn |
| Jun 30, 2025 | 1.77 Mn |
| Jun 30, 2025 | 1.77 Mn |
| Mar 31, 2025 | 595,000.00 |
| Mar 31, 2025 | 595,000.00 |
| Dec 31, 2024 | 437,000.00 |
| Dec 31, 2024 | 437,000.00 |
| Sep 30, 2024 | -2.88 Mn |
| Sep 30, 2024 | -2.88 Mn |
| Jun 30, 2024 | -2.64 Mn |
| Jun 30, 2024 | -2.64 Mn |
| Mar 31, 2024 | 1.14 Mn |
| Mar 31, 2024 | 1.14 Mn |
| Dec 31, 2023 | 38,000.00 |
| Dec 31, 2023 | 38,000.00 |
| Sep 30, 2023 | -1.14 Mn |
| Sep 30, 2023 | -1.14 Mn |